Financing ·
Glucotrack, Inc. filed an amended 8-K to update the terms of a material definitive agreement entered into on July 24…
GCTKGlucotrack, Inc.
Glucotrack, Inc. filed an amended 8-K to update the terms of a material definitive agreement entered into on July 24, 2026. The company partitioned a new promissory note with an original principal amount of $900,000 from an existing debt instrument held by an investor. This partition reduced the outstanding balance of the original note. Under the exchange agreement, the investor may convert portions of this $900,000 note into shares of common stock at a price based on recent Nasdaq closing prices. The conversion is subject to a 9.99% beneficial ownership limitation and requires share delivery by August 31, 2026. Glucotrack, Inc. operates in the healthcare technology industry, developing non-invasive glucose monitoring systems.